The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

The Experimental Surgery Unit and the Preclinical Imaging Platform of VHIR will host several practical classes of the module "Reduction and Refinement in Experimental Design and Methodology," of the Master's in Laboratory Animal Science and Welfare

The communication is part of a study aimed at identifying the mechanisms of progression of Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis, a rare disease that affects the kidneys.

The study on the effects of diesel particles on the heart has been recognized as the best research work from Spain at the association’s Scientific Sessions.

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

The experience of our teaching staff and research groups, the commitment to professional development and the tutorial action plan are highlighted.

A study jointly led by the Hospital Clínic of Barcelona and the Vall d'Hebron Research Institute (VHIR) confirms the effectiveness of neonatal screening in reducing morbidity among children with sickle cell disease (SCD).

This appointment is an international recognition of VHIR's immunodeficiency research.

Active participation by patients and families in studies helps identify more effective therapies that improve quality of life and survival.

Vall d'Hebron has coordinated this initiative that has carried out numerous training and community awareness activities aimed at empowering young people in sexual and reproductive health issues.

Hybrids VITA, developed together with Medical Simulator, reproduces different clinical scenarios for training on how to prevent, diagnose and treat possible complications of ECMO, which is a very complex technique.

The conclusions from the 1st International Congress on Health Communication will provide the basis for a Guide to Health Communication, which will be share with the European University Hospital Alliance (EUHA).

Practical workshops and the Meet the Expert session, so that attendees could interact directly with some of the speakers, complete the round tables.

More than 400 professionals from the fields of health, communication, and political institutions exchange reflections and experiences. Experts warn about the impact of misinformation and the need for transparent and effective communication

A study by the Infectious Diseases group at VHIR has found that some people with HIV can uniquely control the virus thanks to a special type of cell in their immune system.

The awarded projects will study the immune response to HIV and the VIGex tool as a biomarker for immunotherapy response.

Extracorporeal Cardiopulmonary Resuscitation (ECPR) offers therapeutic options for patients in whom conventional cardiopulmonary resuscitation techniques fail to restore the heartbeat.

Over 24 and 25 October, the congress will look into different issues, including communication for government health policies, the relationship between health institutions and journalists or crisis scenarios.

For three days, the III Stroke Congress of the national RICORS-ICTUS network and a symposium focused on cerebral haemorrhage were held.

The funds will strengthen research lines focused on nervous system tumors.

The European Rare Diseases Research Alliance (ERDERA) kicked off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond.

UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.

Welcoming the students of the 1st edition of the Master’s in Clinical Trials Management and Coordination and the 11th edition of the Master’s in Translational Biomedical Research.

On World Cancer Research Day, we highlight research aimed at improving treatments for both pediatric and adult cancers through innovative techniques.